Neutrophils: Old cells in IBD, new actors in interactions with the gut microbiota

Camille Danne

doi:10.1002/ctm2.1739

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (6) : e1739 DOI: 10.1002/ctm2.1739

COMMENTARY

Neutrophils: Old cells in IBD, new actors in interactions with the gut microbiota

Camille Danne ¹^,²^,^†

Author information +

History +

PDF

Keywords

IBD / intestinal inflammation / microbiota / neutrophil

Cite this article

Download citation ▾

Camille Danne. Neutrophils: Old cells in IBD, new actors in interactions with the gut microbiota. Clinical and Translational Medicine, 2024, 14(6): e1739 DOI:10.1002/ctm2.1739

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Danne C, Skerniskyte J, Marteyn B, Sokol H. Neutrophils: from IBD to the gut microbiota. Nat Rev Gastroenterol Hepatol. 2024;21(3):184-197.

[2]	Plichta DR, Graham DB, Subramanian S, Xavier RJ. Therapeutic opportunities in inflammatory bowel disease: mechanistic dissection of host-microbiome relationships. Cell. 2019;178(5):1041-1056.

[3]	Wéra O, Lancellotti P, Oury C. The dual role of neutrophils in inflammatory bowel diseases. JCM. 2016;5(12):118.

[4]	Hugot J-P, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411(6837):599-603.

[5]

Mortha A, Remark R, Del Valle DM, et al. Neutralizing anti–granulocyte-macrophage–colony-stimulating factor autoantibodies recognize post-translational glycosylations on granulocyte-macrophage–colony-stimulating factor years before diagnosis and predict complicated Crohn's Disease. Gastroenterology. 2022;163(3):659-670.

[6]	Danne C, Michaudel C, Skerniskyte J, et al. CARD9 in neutrophils protects from colitis and controls mitochondrial metabolism and cell survival. Gut. 2023;72:1081-1092.

[7]	Zhang D, Frenette PS. Cross talk between neutrophils and the microbiota. Blood. 2019;133(20):2168-2177.

[8]	Maslowski KM, Vieira AT, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461(7268):1282-1286.

[9]	Li G, Lin J, Zhang C, et al. Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease. Gut Microbes. 2021;13(1):1968257.

[10]	Alexeev EE, Dowdell AS, Henen MA, et al. Microbial-derived indoles inhibit neutrophil myeloperoxidase to diminish bystander tissue damage. FASEB J. 2021;35(5):e21552.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.